Trademark Search in Canada

LYBALVI

View On IC.GC.CA

REGISTERED

on 4 Mar 2022

Last Applicant/ Owned by

ALKERMES PHARMA IRELAND LIMITED

Connaught House 1 Burlington Road Dublin

Serial Number

1936431 filed on 17^th Dec 2018

Registration Number

TMA1122033 registered on 4^th Mar 2022

Registration expiry Date

4^th Mar 2032

Correspondent Address

PERRY + CURRIER

1300 YONGE STREETSUITE 500TORONTO

ONTARIO

M4T1X3

LYBALVI

Trademark usage description

pharmaceutical preparations for the treatment of psychiatric and neurodegenerative diseases and disorders namely schizophrenia, depression, major depr Read More

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of psychiatric and neurodegenerative diseases and disorders namely schizophrenia, depression, major depressive disorder, stress, anxiety, treatment resistant depression, bipolar depression, bipolar disorder; pharmaceutical preparations for the mitigation of weight gain and the treatment of metabolic diseases and dyslipidemia.

Classification kind code

Mark Details

Serial Number

1936431

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 55 on 4^th Mar 2022	Registered
Submitted for opposition 190 on 23^rd Feb 2022	Registration Pending
Submitted for opposition 191 on 23^rd Feb 2022	Registration Fee Notice Sent
Submitted for opposition 42 on 1^st Dec 2021	Advertised
Submitted for opposition 26 on 3^rd Nov 2021	Approved
Submitted for opposition 27 on 3^rd Nov 2021	Approval Notice Sent
Submitted for opposition 22 on 28^th Oct 2021	Search Recorded
Submitted for opposition 31 on 21^st Dec 2018	Formalized
Submitted for opposition 1 on 18^th Dec 2018	Created
Submitted for opposition 30 on 17^th Dec 2018	Filed